Proficio Capital Partners LLC Invests $662,000 in Corteva, Inc. $CTVA

Proficio Capital Partners LLC purchased a new stake in Corteva, Inc. (NYSE:CTVA) in the second quarter, according to its most recent filing with the SEC. The fund purchased 7,814 shares of the company’s stock, valued at approximately $662,000.

A number of other large investors have also modified their holdings of CTVA. EFG International AG acquired a new stake in Corteva in the 2nd quarter valued at about $25,000. Compass Financial Management LLC purchased a new stake in shares of Corteva during the second quarter worth $25,000. JPL Wealth Management LLC bought a new stake in Corteva in the third quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva during the 4th quarter valued at $27,000. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of Corteva in the 4th quarter valued at $28,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CTVA. Royal Bank Of Canada lifted their target price on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a report on Tuesday, July 21st. CICC Research raised their price target on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Jefferies Financial Group raised their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. BMO Capital Markets upped their target price on Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Finally, UBS Group decreased their price target on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 18th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Stock Performance

Shares of NYSE CTVA opened at $83.08 on Thursday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The stock has a 50 day moving average of $82.51 and a 200-day moving average of $80.45. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $55.43 billion, a P/E ratio of 55.02, a P/E/G ratio of 2.55 and a beta of 0.57.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.